According to the Market Statsville Group (MSG), the Global Dual Channel Deep Brain Stimulation (DBS) Devices Market size was valued at USD 1,091.9 million in 2023 and is expected to grow from USD 1,257.2 million in 2024 to USD 3,307.4 million by 2033, by exhibiting a CAGR of 11.7% during the forecast period (2024-2033).
A high growth rate is estimated for the dual channel deep brain stimulation devices market, driven by neurological disorders, especially Parkinson's disease, essential tremor, dystonia, and others. These devices generate electrical impulses that aid in stimulating those areas where the implant is placed within the brain, offering relief with therapeutic benefits to patients who have become refractory to pharmaceutical treatment.
Other technological appliances, such as improved battery life and device precision, are also boosting this market. Another factor contributing to this is increased awareness among patients and clinicians about the advantages of DBS therapy. Advanced healthcare infrastructure and higher spending on health drive the North American and European regions, while rapid growth is shown in the Asia-Pacific region due to increasing investments in healthcare and a growing patient pool. Key market players emphasize strategic collaborations and product innovations to enhance their market position and meet the present demand for advanced DBS solutions.
Definition of the Dual Channel Deep Brain Stimulation (DBS) Devices
The Dual Channel Deep Brain Stimulation (DBS) Devices segment relates to medical devices that modulate electrical impulses via two channels in different brain sections. These devices are primarily deployed in diseases of the nervous system, notably Parkinson's disease, essential tremor, and dystonia—one which confers huge therapeutic benefits from the devices for patients who previously failed to respond to conventional medications.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/dual-channel-deep-brain-stimulation-dbs-devices-market?utm_source=free&utm_medium=harsh
Scope of the Global Dual Channel Deep Brain Stimulation (DBS) Devices Market
The study categorizes the Dual Channel Deep Brain Stimulation (DBS) Devices market based on type, application, and end-user area at the regional and global levels.
By Type Outlook (Sales, USD Million, 2019-2033)
- Rechargeable DBS
- Non-rechargeable DBS
By Application Outlook (Sales, USD Million, 2019-2033)
- Parkinson's Disease
- Essential Tremor
- Dystonia
- Others
By End-User Outlook (Sales, USD Million, 2019-2033)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
By Region Outlook (Sales, USD Million, 2019-2033)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- UK
- Spain
- Poland
- Russia
- The Netherlands
- Norway
- Czech Republic
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Indonesia
- Malaysia
- Thailand
- Singapore
- Australia & New Zealand
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- The Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Northern Africa
- Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/dual-channel-deep-brain-stimulation-dbs-devices-market?opt=3338&utm_source=free&utm_medium=harsh
Parkinson's disease segment accounts for the largest market share by application
Based on the application, the market is divided into Parkinson's Disease, Essential Tremor, Dystonia, and Others. The infotainment segment accounted for the largest market share in the global Dual Channel Deep Brain Stimulation (DBS) Devices market. The Parkinson's disease application segment dominated the Dual Channel Deep Brain Stimulation (DBS) Devices market due to the high prevalence across the world and the high therapeutic benefit provided by DBS therapy in symptomatic treatment. It is a neurological disorder wherein, over time, motor symptoms manifest, such as tremors, rigidity, and bradykinesia, conclusively impairing the patient's quality of life. Devices for deep brain stimulation effectively alleviate those motor symptoms by providing electrical impulses to targeted areas in the brain, thus reducing motor fluctuations and enhancing patient mobility and function. Extensive clinical research and long-term successful treatment outcomes of DBS in Parkinson's disease have been a factor in strengthening its wide adoption by healthcare practitioners and patients alike, further cementing Parkinson's disease for driving growth in the DBS devices market.
North America accounted for the largest market share by Region
Based on the regions, the global market of Dual Channel Deep Brain Stimulation (DBS) Devices has been segmented across North America, Europe, the Middle East & Africa, South America, and Asia-Pacific. North America dominates the dual channel deep brain stimulation devices market due to the development of healthcare infrastructure and high expenditure on healthcare. Further, it holds a significant prevalence of neurological disorders, such as Parkinson's disease, essential tremor, and dystonia, which would propel demand for an effective treatment against such diseases. Besides this, it is highly penetrated with significant players, which would motivate them to innovate and develop DBS technologies without any stop.
Furthermore, regulatory bodies support good reimbursement policies and promote the growth of the market. Extensive research and development activity with clinical trials will ensure that cutting-edge solutions and improvements in DBS devices come to the market. Well-structured healthcare in this region will enable easy diffusion of these medical technologies, and North America is the leading market for DBS devices.
Competitive Landscape: Global Dual Channel Deep Brain Stimulation (DBS) Devices Market
The competitive landscape of the global Dual Channel Deep Brain Stimulation (DBS) Devices market is such that prominent players are impelled to innovate and collaborate on strategic initiatives. Key companies in this segment have been heavily investing in the creation of advanced DBS technologies, geographical reach, and broadening their product offerings to fight for dominance in this fast-growing medical device space.
Major players in the global Dual Channel Deep Brain Stimulation (DBS) Devices market are:
- Medtronic
- Boston Scientific
- Abbott
- Beijing Pins
- SceneRay
- Fisher Wallace
- Aleva Neurotherapeutics SA
- NeuroPace Inc.
- Other Major Players
Request For Report Toc: https://www.marketstatsville.com/table-of-content/dual-channel-deep-brain-stimulation-dbs-devices-market
Recent Developments
- In January 2024, The US FDA granted Medtronic the approval of its Percept RC deep brain stimulation device for the treatment of movement disorders and Parkinson's disease.
- In January 2024, Abbott announced that, based on the review the company submitted, the US FDA expanded the current indicated approval for it to market the world's smallest rechargeable deep brain stimulation device with remote programming, the Libera RCTM DBS System, for the treatment of movement disorders in patients.
Comments
0 comment